Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTA-16: Varespladib in Acute Coronary Syndrome
NCT01130246Phase 3Terminated
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- May 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of varespladib methyl in acute coronary syndrome (ACS), sponsored by Anthera Pharmaceuticals, Inc.. Started May 2010; status: terminated.
02
Drugs
varespladib methyl
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01130246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01130246.